ADAC refines high-energy MCD protocol

December 4, 1996

Nuclear medicine vendor ADAC Laboratories of Milpitas, CA, beganshipping its Molecular Coincidence Detection high-energy imagingupgrade this year, and reported that it had received 27 ordersfor MCD upgrades through the end of its fiscal year in

Nuclear medicine vendor ADAC Laboratories of Milpitas, CA, beganshipping its Molecular Coincidence Detection high-energy imagingupgrade this year, and reported that it had received 27 ordersfor MCD upgrades through the end of its fiscal year in September.ADAC plans to show improvements in reconstruction algorithms forMCD at its RSNA booth, according to Jeff Nelson, vice presidentof marketing.

Also look for ADAC to present final results of its multicenterclinical trial for Vantage, an attenuation-correction feature.The results indicate that Vantage can help reduce false positivesin nuclear cardiology studies, Nelson said. ADAC has developeda second-generation version of Vantage that incorporates scattercorrection and gated SPECT.

Vertex Plus is the third generation of ADAC's variable-angledual-head gamma camera, and features improvements to the system'sergonomics and patient handling, according to Nelson.

The most interesting news at ADAC's booth, however, isn't relatedto a new product, but rather an acquisition with intriguing ramifications:sources indicate the vendor will annouce the purchase of managedservice organization Medical Transition Strategies of Atlanta,the parent of Georgia Radiology Network.

ADAC is expected to form a new business unit to encompass itswork in developing physician networks that can contract with payorslike managed-care organizations. ADAC could use Georgia RadiologyNetwork as a model in setting up radiology networks in other states.The company declined to comment officially on the acquisitionprior to the RSNA show.